Director
DIN: 09560888
Rohit Mandholia is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at MEDIAIR HEALTHCARE PRODUCTS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09560888.Rohit Mandholia has previously been associated with 1 company in roles such as Additional Director.Rohit Mandholia is currently involved in 2 different roles. Their most recent position is with MANDHOLIA ESTATES LLP as a Designated Partner. The first company Rohit Mandholia was appointed to as a director was MEDIAIR HEALTHCARE PRODUCTS PRIVATE LIMITED. Rohit Mandholia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rohit Mandholia is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at MEDIAIR HEALTHCARE PRODUCTS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09560888.Rohit Mandholia has previously been associated with 1 company in roles such as Additional Director.Rohit Mandholia is currently involved in 2 different roles. Their most recent position is with MANDHOLIA ESTATES LLP as a Designated Partner. The first company Rohit Mandholia was appointed to as a director was MEDIAIR HEALTHCARE PRODUCTS PRIVATE LIMITED. Rohit Mandholia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MEDIAIR HEALTHCARE PRODUCTS PRIVATE LIMITED | Director | 30-Sep-2022 |